Skip to main content
. Author manuscript; available in PMC: 2022 Jan 6.
Published in final edited form as: J Cyst Fibros. 2021 Jun 6;20(4):692–698. doi: 10.1016/j.jcf.2021.05.015

Table 2.

Minimal Inhibitory Concentration under aerobic and anaerobic conditions

MIC μg/mL Vanco-mycin Linezolid Fusidic Acid *, (n=91) Rifampin*
(n=82)
TMP-SMX Clindamycin* (n=69)
Aerobic 0.74±0.02 1.14±0.06 0.09±0.007 0.04±0.02 0.04±0.02 0.06±0.002
Anaerobic 0.58±0.02 1.10±0.07 0.04±0.006 0.03±0.014 0.08±0.02 0.09±0.006
p-value <0.0001 0.63 <0.0001 <0.0001 <0.0001 <0.0001

MIC in μg/mL reported as mean ± standard error of the mean of triplicate testing for incident and chronic isolates.

*

Pairs with one or both resistant isolates per CLSI breakpoints were excluded.

EUCAST criteria as CLSI breakpoints for fusidic acid are not available. Comparisons between aerobic and anaerobic conditions are by Wilcoxon matched pairs signed rank test.